Accepted at 2:50 p.m. Apr, 11, 2024 by herstein.jacob
Author: dooshemama
Co-authors: herstein.jacob
Related Note: 1489967019558
Rationale for change

Adding tremor as a common neurotoxic manifestation per UWorld: 3980

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#UWorld::COMLEX::100772 #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::01_Cyclosporine #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::02_Tacrolimus #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Tacrolimus #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#AMBOSS::IlaYyk #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::Transplant-Rejection-Prophylaxis #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Cyclosporine #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::03_Immunosuppressants #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::07_Immunosuppressants #AK_Step2_v12::#AMBOSS::fF0kh3 #AK_Step1_v12::#B&B::13_Immunology::03_Pharm::02_Immunosuppressive_Drugs #AK_Step2_v12::#SketchyIM::06_Electrolytes_&_Acid_Base::04_Retired_Lessons::03_Hyperkalemia_Ddx_&_Management_[OLD_VERSION] #AK_Step2_v12::#UWorld::Step::3980 #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::02_Tacrolimus #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pixorize::02_Immunology::09_Immunosuppressants::01_Cyclosporine #AK_Step1_v12::#AMBOSS #AK_Step1_v12::^Other::^EXPN